pa-56-29-1015: Extension of temporary scheduling of substance; Nitazene class of compounds

Summary

The Secretary of Health (Secretary) of the Department of Health (Department) is extending the temporary scheduling of any material, compound, mixture or preparation which contains any quantity of the following Nitazene substances, their salts, isomers and salts of isomers: Butonitazene, Etodesnitazene, Flunitazene, Isotonitazene, Metodesnitazene, Metonitazene and Protonitazene (Nitazene class of compounds), for an additional year. On July 19, 2025, the Secretary issued a final order temporarily scheduling the Nitazene class of compounds that were not at the time listed in any schedule of The Controlled Substance, Drug, Device and Cosmetic Act (act) (35 P.S. §§ 780-101 780-144). This extension of the temporary scheduling will maintain the Nitazene class of compounds in Schedule I under the act while the Secretary goes forward with permanently scheduling the Nitazene class of compounds as schedule I substances. Background The United States Drug Enforcement Administration (DEA) has scheduled several Nitazene substances, their salts, isomers and salts of isomers including: Butonitazene, Etodesnitazene, Flunitazene, Isotonitazene, Metodesnitazene, Metonitazene and Protonitazene, as Schedule I controlled substances under the Federal Controlled Substance Act (CSA) (21 U.S.C. §§ 801 971). Under the CSA, every controlled substance is classified into one of five schedules based upon its potential for abuse, its currently accepted medical use in treatment in the United States and the...

The agency’s own summary, as published.